Literature DB >> 22112678

Inhaled nitric oxide therapy for secondary pulmonary hypertension with hypertrophic obstructive cardiomyopathy and severe kyphoscoliosis.

Yusuke Hosokawa, Takeshi Yamamoto, Yuto Yabuno, Keisuke Hara, Toshiyuki Aokage, Keiko Nakazato, Hiroomi Suzuki, Manabu Suzuki, Akira Ueno, Ryo Munakata, Yukichi Tokita, Eisei Yamamoto, Koichi Akutsu, Hitoshi Takano, Naoki Sato, Morimasa Takayama, Keiji Tanaka, Kyoichi Mizuno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22112678     DOI： 10.1016/j.ijcard.2011.10.039

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

1.  Pulmonary Hypertension and Its Response to Treatment in a Patient with Kyphosis-related Alveolar Hypoventilation.

Authors:  Shinji Okada; Ayumi Sugawara; Shunsuke Yamagata; Satoshi Takeuchi; Zenta Watanuki
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

2.  Long-Term Response to Vasoactive Treatment in a Case of Kyphoscoliosis-Associated Pulmonary Hypertension.

Authors:  Jonas Tellermann; Matiss Sablinskis; Patricia Raquel Ribeiro Machado; Kristaps Sablinskis; Andris Skride
Journal:  Am J Case Rep       Date:  2019-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.